C4 Therapeutics
CCCC
CCCC
96 hedge funds and large institutions have $117M invested in C4 Therapeutics in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 26 increasing their positions, 37 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 102 → 96 (-6)
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
30% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 37
Holders
96
Holding in Top 10
1
Calls
$806K
Puts
$645K
Top Buyers
| 1 | +$4.21M | |
| 2 | +$1.85M | |
| 3 | +$1.07M | |
| 4 |
SC
Shay Capital
New York
|
+$932K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$831K |
Top Sellers
| 1 | -$5.71M | |
| 2 | -$3.54M | |
| 3 | -$1.13M | |
| 4 |
Goldman Sachs
New York
|
-$933K |
| 5 |
Jane Street
New York
|
-$642K |
